Page last updated: 2024-11-02

pamidronate and Uveitis

pamidronate has been researched along with Uveitis in 6 studies

Uveitis: Inflammation of part or all of the uvea, the middle (vascular) tunic of the eye, and commonly involving the other tunics (sclera and cornea, and the retina). (Dorland, 27th ed)

Research Excerpts

ExcerptRelevanceReference
"Ophthalmologic adverse effects of bisphosphonate therapy are infrequent and of unclear pathogenesis."6.41Uveitis, an under-recognized adverse effect of pamidronate. Case report and literature review. ( Acquaviva, PC; Bernard, P; Dahan, L; Daumen-Legré, V; Lafforgue, P; Pham, T; Rey, J, 2000)
"Ophthalmologic adverse effects of bisphosphonate therapy are infrequent and of unclear pathogenesis."2.41Uveitis, an under-recognized adverse effect of pamidronate. Case report and literature review. ( Acquaviva, PC; Bernard, P; Dahan, L; Daumen-Legré, V; Lafforgue, P; Pham, T; Rey, J, 2000)
"Uveitis and scleritis are the most serious ocular side effects of bisphosphonate therapy."1.35Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort. ( French, DD; Margo, CE, 2008)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's4 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
French, DD1
Margo, CE1
Fraunfelder, FW1
Winthrop, K1
Suhler, E1
Choi, D1
Fraunfelder, FT1
Alegre de Miquel, C1
Moreno-Ruzafa, E1
González-Fernández, MJ1
De, S1
Meyer, P1
Crisp, AJ1
Ghose, K1
Waterworth, R1
Trolove, P1
Highton, J1
Rey, J1
Daumen-Legré, V1
Pham, T1
Bernard, P1
Dahan, L1
Acquaviva, PC1
Lafforgue, P1

Reviews

1 review available for pamidronate and Uveitis

ArticleYear
Uveitis, an under-recognized adverse effect of pamidronate. Case report and literature review.
    Joint bone spine, 2000, Volume: 67, Issue:4

    Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Dexamethasone; Diclofenac; Diphos

2000

Other Studies

5 other studies available for pamidronate and Uveitis

ArticleYear
Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort.
    Retina (Philadelphia, Pa.), 2008, Volume: 28, Issue:6

    Topics: Administration, Oral; Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Databa

2008
Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort.
    Retina (Philadelphia, Pa.), 2009, Volume: 29, Issue:2

    Topics: Administration, Oral; Alendronate; Bone Density Conservation Agents; Databases, Factual; Diphosphona

2009
[Pamidronate and uveitis].
    Medicina clinica, 2005, Nov-12, Volume: 125, Issue:17

    Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Pamidronate; Uveitis

2005
Pamidronate and uveitis.
    British journal of rheumatology, 1995, Volume: 34, Issue:5

    Topics: Diphosphonates; Female; Humans; Middle Aged; Osteitis Deformans; Pamidronate; Streptococcus pneumoni

1995
Uveitis associated with pamidronate.
    Australian and New Zealand journal of medicine, 1994, Volume: 24, Issue:3

    Topics: Diphosphonates; Humans; Male; Middle Aged; Osteitis Deformans; Pamidronate; Uveitis; Uveitis, Anteri

1994